Glaucoma Drainage Devices Market is segmented By Product Type (Minimally Invasive Glaucoma Surgery (MIGS) Devices, Schlemm’s Canal MIGS Devices, Supra....
Market Size in USD
CAGR11.9%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 11.9% |
Market Concentration | High |
Major Players | Johnson & Johnson, AbbVie Inc, Alcon Inc, Glaukos Corporation, Santen Pharmaceutical Co., Ltd |
The Global Glaucoma Drainage Devices Market is estimated to be valued at USD 640.5 million in 2024 and is expected to reach USD 1,184.3 million by 2031, growing at a compound annual growth rate (CAGR) of 11.9% from 2024 to 2031. Glaucoma drainage devices help reduce intraocular pressure by diverting aqueous humor from the anterior chamber of the eye to the conjunctival space or episcleral vessels, thus treating conditions such as refractory glaucoma.
The market is expected to witness significant growth during the forecast period due to the rising geriatric population globally which are more prone to developing glaucoma. Additionally, technological advancements in glaucoma drainage devices along with increasing awareness regarding early glaucoma screening and treatment options available are some key factors driving the growth of this market.